ArticleMedical oncology (Northwood, London, England)2024

Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation.

Saptarshi Sinha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.